Open
SectorHealthcare
57.01 3.49
24h
Min
54.81
Max
58.9
Income | -11M -77M |
---|---|
Sales | -11M 11M |
EPS | -0.95 |
Profit margin | -667.602 |
Employees | 218 |
EBITDA | -21M -85M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +17.33% upside |
Next Earnings | 31 paź 2025 |
---|
Market Cap | 1.5B 4.2B |
---|---|
Previous open | 53.52 |
Previous close | 57.01 |
By Acuity
50%
50%
149 / 371 Ranking in Healthcare
By Trading Central
Confidence
Weak Bullish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 64.13 USD 17.33%
High 88 USD
Low 53 USD
Based on 17 Wall Street analysts offering 12 month price targets forKymera Therapeutics Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$